These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33531691)

  • 1. CREPT/RPRD1B promotes tumorigenesis through STAT3-driven gene transcription in a p300-dependent manner.
    Zhai W; Ye X; Wang Y; Feng Y; Wang Y; Lin Y; Ding L; Yang L; Wang X; Kuang Y; Fu X; Eugene Chin Y; Jia B; Zhu B; Ren F; Chang Z
    Br J Cancer; 2021 Apr; 124(8):1437-1448. PubMed ID: 33531691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CREPT facilitates colorectal cancer growth through inducing Wnt/β-catenin pathway by enhancing p300-mediated β-catenin acetylation.
    Zhang Y; Wang S; Kang W; Liu C; Dong Y; Ren F; Wang Y; Zhang J; Wang G; To KF; Zhang X; Sung JJ; Chang Z; Yu J
    Oncogene; 2018 Jun; 37(26):3485-3500. PubMed ID: 29563608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
    Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
    J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer.
    Ding L; Yang L; He Y; Zhu B; Ren F; Fan X; Wang Y; Li M; Li J; Kuang Y; Liu S; Zhai W; Ma D; Ju Y; Liu Q; Jia B; Sheng J; Chang Z
    Cell Death Dis; 2018 Dec; 9(12):1172. PubMed ID: 30518842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CREPT accelerates tumorigenesis by regulating the transcription of cell-cycle-related genes.
    Lu D; Wu Y; Wang Y; Ren F; Wang D; Su F; Zhang Y; Yang X; Jin G; Hao X; He D; Zhai Y; Irwin DM; Hu J; Sung JJ; Yu J; Jia B; Chang Z
    Cancer Cell; 2012 Jan; 21(1):92-104. PubMed ID: 22264791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression.
    Li J; Smith AR; Marquez RT; Li J; Li K; Lan L; Wu X; Zhao L; Ren F; Wang Y; Wang Y; Jia B; Xu L; Chang Z
    Mol Carcinog; 2018 Oct; 57(10):1408-1420. PubMed ID: 29938829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen.
    Ray S; Boldogh I; Brasier AR
    Gastroenterology; 2005 Nov; 129(5):1616-32. PubMed ID: 16285960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CREPT regulated by miR-138 promotes breast cancer progression.
    Liang Z; Feng Q; Xu L; Li S; Zhou L
    Biochem Biophys Res Commun; 2017 Nov; 493(1):263-269. PubMed ID: 28893536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knocking-down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression.
    Ma J; Ren Y; Zhang L; Kong X; Wang T; Shi Y; Bu R
    PLoS One; 2017; 12(4):e0174309. PubMed ID: 28369091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell-permeable peptide-based PROTAC against the oncoprotein CREPT proficiently inhibits pancreatic cancer.
    Ma D; Zou Y; Chu Y; Liu Z; Liu G; Chu J; Li M; Wang J; Sun SY; Chang Z
    Theranostics; 2020; 10(8):3708-3721. PubMed ID: 32206117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17 induces NSCLC cell migration and invasion by elevating MMP19 gene transcription and expression through the interaction of p300-dependent STAT3-K631 acetylation and its Y705-phosphorylation.
    Ge W; Li YA; Ruan Y; Wu N; Ma P; Xu T; Shu Y; Wang Y; Qiu W; Zhao C
    Oncol Res; 2024; 32(4):625-641. PubMed ID: 38560562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a monoclonal antibody against CREPT, a novel protein highly expressed in tumors.
    Ren F; Wang R; Zhang Y; Liu C; Wang Y; Hu J; Zhang L; Chang Z
    Monoclon Antib Immunodiagn Immunother; 2014 Dec; 33(6):401-8. PubMed ID: 25545209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P300-dependent STAT3 acetylation is necessary for angiotensin II-induced pro-fibrotic responses in renal tubular epithelial cells.
    Ni J; Shen Y; Wang Z; Shao DC; Liu J; Kong YL; Fu LJ; Zhou L; Xue H; Huang Y; Zhang W; Yu C; Lu LM
    Acta Pharmacol Sin; 2014 Sep; 35(9):1157-66. PubMed ID: 25088002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine-Phosphorylated STAT3 Promotes Tumorigenesis via Modulation of RNA Polymerase Transcriptional Activity.
    Balic JJ; Garama DJ; Saad MI; Yu L; West AC; West AJ; Livis T; Bhathal PS; Gough DJ; Jenkins BJ
    Cancer Res; 2019 Oct; 79(20):5272-5287. PubMed ID: 31481496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin-dependent kinase 5 modulates STAT3 and androgen receptor activation through phosphorylation of Ser⁷²⁷ on STAT3 in prostate cancer cells.
    Hsu FN; Chen MC; Lin KC; Peng YT; Li PC; Lin E; Chiang MC; Hsieh JT; Lin H
    Am J Physiol Endocrinol Metab; 2013 Oct; 305(8):E975-86. PubMed ID: 23941877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
    Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
    Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CREPT Disarms the Inhibitory Activity of HDAC1 on Oncogene Expression to Promote Tumorigenesis.
    Cao Y; Ning B; Tian Y; Lan T; Chu Y; Ren F; Wang Y; Meng Q; Li J; Jia B; Chang Z
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-activator SRC-1 is dispensable for transcriptional control by STAT3.
    Cvijic H; Bauer K; Löffler D; Pfeifer G; Blumert C; Kretzschmar AK; Henze C; Brocke-Heidrich K; Horn F
    Biochem J; 2009 Apr; 420(1):123-32. PubMed ID: 19203349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.
    Hou T; Ray S; Lee C; Brasier AR
    J Biol Chem; 2008 Nov; 283(45):30725-34. PubMed ID: 18782771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.